Training series highlights solutions for HIV and COVID-19 screenings in primary care WASHINGTON , April 26, 2023 /PRNewswire/ -- The George Washington University School of Medicine and Health Sciences (SMHS) is hosting a free ...
TURKU, Finland , March 15, 2023 /PRNewswire/ -- DelSiTech Ltd, a Finnish drug delivery and drug development company, today announces that it has been awarded a grant from the Bill & Melinda Gates Foundation to develop long-acting ...
OTTAWA, ON , Dec. 1, 2022 /CNW/ - Today marks World AIDS Day and the beginning of Indigenous AIDS Awareness Week . These events provide an opportunity to raise awareness of HIV/AIDS, support those living with HIV, and remember the ...
OTTAWA, ON , Dec. 1, 2022 /CNW/ - December 1 marks World AIDS Day and the beginning of Indigenous AIDS Awareness Week . During this time, we remember those who we lost to human immunodeficiency virus (HIV) as we continue to show our ...
OTTAWA, ON , Dec. 1, 2022 /CNW/ - Today, during a World AIDS Day flag raising ceremony, the Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Carolyn Bennett , Minister of Mental Health and Addictions, and Associate ...
HANGZHOU and SHAOXING, China , Sept. 15, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide for functional cure ...
- STP0404 is the only clinical safety proven HIV treatment candidate with a novel mechanism that can block HIV re-activation. - STP0404 is expected to enter Phase 2a clinical trial in the US in 4Q 2022. SEOUL, South Korea , Aug. 3, ...
New investments in decentralized testing will support progress toward ending HIV as a public health concern by 2030. MONTREAL , Aug. 1, 2022 /CNW Telbec/ - Public Health Agency of Canada We know that there are nearly 63,000 people ...
Beginning the analytic treatment interruption is a pivotal step to potentially demonstrating a gene therapy cure for HIV. ROCKVILLE, Md. , July 28, 2022 /PRNewswire-PRWeb/ -- American Gene Technologies , a clinical-stage ...
HANGZHOU and SHAOXING, China , July 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human ...
Mother-to-child HIV transmission remains a critical challenge in India, demanding urgent action to enhance prevention, early detection, and treatment measures.
Afghanistan reports 200 new AIDS cases in 2024, highlighting the growing need for improved healthcare and prevention efforts in the region.
Sunlenca's biannual shot could revolutionize HIV prevention, but access remains a key barrier, particularly in Latin America.
APSACS Director highlights the need for increased HIV treatment access in Andhra Pradesh while emphasizing youth involvement and global efforts to eradicate HIV by 2030.
A resurgence of HIV/AIDS in the Western Pacific raises alarms, highlighting the urgent need for awareness, prevention, and improved healthcare responses in the region.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers